Q3 2015
Released Nov 10, 2015, after the close
10-Q filed Nov 10, 2015, 41 days after period end · 0001144204-15-064180
Q3 2015 · 10-Q
Revenue$320.00K$320.00K −34.8% vs Q3 2014−43.6% vs Q2 2015
Net Income-$581.00K-$581.00K N/M vs Q3 2014N/M vs Q2 2015
EPS Diluted-$0.02-$0.02 N/M vs Q3 2014N/M vs Q2 2015
Gross Profit$166,000−47.5%
Operating Income-$1,087,000N/M
Operating Cash Flowderived-$1,124,000N/M
Margins · derived
Gross margin51.9%−12.5 pt vs Q3 2014
Operating margin-339.7%−201.0 pt vs Q3 2014
Net margin-181.6%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $320.00K | $491.00K | $418.00K | $604.00K |
| Net Income | -$581.00K | $2.72M | -$2.41M | -$853.00K |
| EPS Diluted | -$0.02 | -$0.02 | -$0.14 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR